RT Journal Article SR Electronic T1 Prophylactic dose fondaparinux for 6 weeks in superficial thrombophlebitis of the legs reduces the risk for symptomatic thromboembolic complications JF Evidence Based Medicine JO Evid Based Med FD BMJ Publishing Group Ltd SP 28 OP 29 DO 10.1136/eb-2012-100755 VO 18 IS 1 A1 Maria T DeSancho A1 Stephen M Pastores YR 2013 UL http://ebm.bmj.com/content/18/1/28.abstract AB